The global essential thrombocythemia market is on track for significant expansion, with projections indicating a valuation of USD 865.36 million by 2023 and a robust compound annual growth rate (CAGR) of 5.8% from 2023 to 2033. By 2033, the market is anticipated to reach an impressive USD 1,520.74 million. Essential thrombocythemia, a rare blood disorder …